Genomic Alteration in Metastatic Breast Cancer and Its Treatment

Genomic Alteration in Metastatic Breast Cancer and Its Treatment

4.7
(613)
Write Review
More
$ 19.00
Add to Cart
In stock
Description

Metastatic Breast Cancer Patients Benefit from Targeted Therapies

Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology. - Abstract - Europe PMC

Groundbreaking Study Suggests Some Breast Cancer Patients May Skip

Functionalized liposomes for targeted breast cancer drug delivery - ScienceDirect

Genes, Free Full-Text

Current Oncology, Free Full-Text

JCM, Free Full-Text

Brazilian Journal Of Oncology - Implementing somatic mutation testing in clinical setting: recommendations from a panel of experts

Frontiers Clinical implication of genetic composition and